These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 15330508

  • 21. Field evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo immunoassay.
    Kfutwah A, Lemée V, Ngono HV, De Oliveira F, Njouom R, Plantier JC.
    J Clin Virol; 2013 Dec; 58 Suppl 1():e70-5. PubMed ID: 24342480
    [Abstract] [Full Text] [Related]

  • 22. HIV-1 infection in early seroconversion stage missed by rapid or ELISA tests--two case reports.
    Jindal N, Tiwari R, Aggarwal A, Aggarwal L.
    Indian J Pathol Microbiol; 2005 Jul; 48(3):395-6. PubMed ID: 16761767
    [Abstract] [Full Text] [Related]

  • 23. Diagnostic assays for HIV-1 infection.
    Truong HM, Klausner JD.
    MLO Med Lab Obs; 2004 Jul; 36(7):12-3, 16, 18-20; quiz 22-3. PubMed ID: 15318787
    [No Abstract] [Full Text] [Related]

  • 24. Evaluation of the siemens HIV antigen-antibody immunoassay.
    Vallefuoco L, Aden Abdi F, Sorrentino R, Spalletti-Cernia D, Mazzarella C, Barbato S, Perna E, Buffolano W, Di Nicuolo G, Portella G.
    Intervirology; 2014 Jul; 57(2):106-11. PubMed ID: 24557036
    [Abstract] [Full Text] [Related]

  • 25. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.
    Dubravac T, Gahan TF, Pentella MA.
    J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of Calypte AWARE HIV-1/2 OMT antibody test as a screening test in an Indian setting.
    Ingole NA, Mehta PR, Bande RN, Paranjpe SM, Wanjare SW.
    Indian J Med Microbiol; 2010 Dec; 28(4):295-8. PubMed ID: 20966557
    [Abstract] [Full Text] [Related]

  • 27. [Sensitivity of HIV infection screening assays in 2001].
    Laperche S, Ly TD.
    Ann Biol Clin (Paris); 2002 Dec; 60(3):307-15. PubMed ID: 12050047
    [Abstract] [Full Text] [Related]

  • 28. Diagnostic evaluation of a new combined HIV p24 antigen and anti-HIV1/2/O screening assay.
    Polywka S, Feldner J, Duttmann H, Laufs R.
    Clin Lab; 2001 Dec; 47(7-8):351-6. PubMed ID: 11499796
    [Abstract] [Full Text] [Related]

  • 29. Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection.
    Ly TD, Martin L, Daghfal D, Sandridge A, West D, Bristow R, Chalouas L, Qiu X, Lou SC, Hunt JC, Schochetman G, Devare SG.
    J Clin Microbiol; 2001 Sep; 39(9):3122-8. PubMed ID: 11526139
    [Abstract] [Full Text] [Related]

  • 30. Performance evaluation of the new fully automated human immunodeficiency virus antigen-antibody combination assay designed for blood screening.
    Sickinger E, Jonas G, Yem AW, Goller A, Stieler M, Brennan C, Hausmann M, Schochetman G, Devare SG, Hunt JC, Kapprell HP, Bryant JD.
    Transfusion; 2008 Apr; 48(4):584-93. PubMed ID: 18194389
    [Abstract] [Full Text] [Related]

  • 31. Performance evaluation of the FDA-approved Determine™ HIV-1/2 Ag/Ab Combo assay using plasma and whole blood specimens.
    Masciotra S, Luo W, Westheimer E, Cohen SE, Gay CL, Hall L, Pan Y, Peters PJ, Owen SM.
    J Clin Virol; 2017 Jun; 91():95-100. PubMed ID: 28372891
    [Abstract] [Full Text] [Related]

  • 32. [Screening tests combined with p24 antigen and anti-HIV antibodies in early detection of HIV-1].
    Laperche S, Maniez-Montreuil M, Couroucé AM.
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():18s-24s. PubMed ID: 10919219
    [Abstract] [Full Text] [Related]

  • 33. [Screening of HIV in blood banks. Evaluation of fourth generation kits].
    Canna F, Treviño E, Domínguez C, Gastaldello R, Barbas G, Cudola A, Irizar M, Bepre H, Gallego S.
    Medicina (B Aires); 2003 Jun; 63(6):685-91. PubMed ID: 14719309
    [Abstract] [Full Text] [Related]

  • 34. The risk of a second diagnostic window with 4th generation HIV assays: Two cases.
    Niederhauser C, Ströhle A, Stolz M, Müller F, Tinguely C.
    J Clin Virol; 2009 Aug; 45(4):367-9. PubMed ID: 19546027
    [Abstract] [Full Text] [Related]

  • 35. A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting.
    Jensen TO, Robertson P, Whybin R, Chambers I, Lahra M, Rawlinson W, Post JJ.
    J Clin Microbiol; 2015 May; 53(5):1709-11. PubMed ID: 25673794
    [Abstract] [Full Text] [Related]

  • 36. [Assay for simultaneous detection of HIV p24 antigen and anti-HIV antibody].
    Xu K, Zhang Y, Wang Y, Mbawuike I.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):377-9. PubMed ID: 12665911
    [Abstract] [Full Text] [Related]

  • 37. Prozone effect with the VIDAS HIV DUO Ultra assay.
    Jnaoui K, Lamarti N, Pâques AT, Goubau P.
    J Clin Virol; 2007 Mar; 38(3):273-4. PubMed ID: 17223608
    [No Abstract] [Full Text] [Related]

  • 38. Combination assay detecting both human immunodeficiency virus (HIV) p24 antigen and anti-HIV antibodies opens a second diagnostic window.
    Speers D, Phillips P, Dyer J.
    J Clin Microbiol; 2005 Oct; 43(10):5397-9. PubMed ID: 16208030
    [Abstract] [Full Text] [Related]

  • 39. Acute HIV seroconversion and pneumonitis.
    Casalino E, Bouvet E, Bedos JP, Wolff M, Simon F, Vachon F.
    AIDS; 1991 Sep; 5(9):1143-4. PubMed ID: 1930782
    [No Abstract] [Full Text] [Related]

  • 40. A new combined HIV p24 antigen and anti-HIV-1/2/O screening assay.
    Polywka S, Duttmann H, Lübben F, Laufs R, Feldner J.
    Methods Mol Biol; 2005 Sep; 304():229-43. PubMed ID: 16061980
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.